Literature DB >> 15626596

Statins as coronary vasodilators in isolated bovine coronary arteries--involvement of PGI2 and NO.

Barbara Lorkowska1, Stefan Chlopicki.   

Abstract

Here we studied direct vasodilation induced by statins in isolated bovine coronary arteries. In rings of coronary bovine arteries preconstricted with prostaglandin F(2 alpha) (3 x 10(-8) - 10(-5)), lovastatin, simvastatin, atorvastatin and cerivastatin (3-30 microM) but not pravastatin induced concentration-dependent vasodilation. Removal of endothelium diminished response to simvastatin, cerivastatin and atorvastatin (30 microM) (67.4+/-4.56 vs. 22.7+/-8.14%, 96.9+/-2.27% vs. 54.5+/-6.86%, 67.4+/-4.01% vs. 34.6+/-5.66%, respectively). In presence of L-NAME (300 microM) or indomethacin (5 microM) responses to simvastatin, atorvastatin and cerivastatin, were also partially diminished. In contrast, lovastatin-induced vasorelaxation was not significantly affected by removal of endothelium (35.6+/-4.19% vs. 28.8+/-5.24%) or by pretreatment with L-NAME or indomethacin. In summary, with the exception of pravastatin, statins act as coronary vasodilators. Simvastatin, cerivastatin and atorvastatin but not lovastatin induced vasodilation displayed endothelium dependent- and endothelium-independent components. The endothelium-dependent effect of statins was mediated by NO and PGI(2), while the mechanism of smooth muscle cells-dependent component remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15626596     DOI: 10.1016/j.plefa.2004.10.012

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  3 in total

1.  Acute simvastatin inhibits K ATP channels of porcine coronary artery myocytes.

Authors:  Sai Wang Seto; Alice Lai Shan Au; Christina Chui Wa Poon; Qian Zhang; Rachel Wai Sum Li; John Hok Keung Yeung; Siu Kai Kong; Sai Ming Ngai; Song Wan; Ho Pui Ho; Simon Ming Yuen Lee; Maggie Pui Man Hoi; Shun Wan Chan; George Pak Heng Leung; Yiu Wa Kwan
Journal:  PLoS One       Date:  2013-06-17       Impact factor: 3.240

2.  Efficacy of Laropiprant in Minimizing Brain Injury Following Experimental Intracerebral Hemorrhage.

Authors:  Abdullah Shafique Ahmad; Monique Mendes; Damian Hernandez; Sylvain Doré
Journal:  Sci Rep       Date:  2017-08-25       Impact factor: 4.379

Review 3.  Statin-Induced Nitric Oxide Signaling: Mechanisms and Therapeutic Implications.

Authors:  Armita Mahdavi Gorabi; Nasim Kiaie; Saeideh Hajighasemi; Maciej Banach; Peter E Penson; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  J Clin Med       Date:  2019-11-22       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.